Sugar Sweetened Beverage Consumption
Sugar-sweetened beverages (SSBs) encompass a wide range of drinks, including soft drinks, fruit drinks, sports drinks, and sweetened teas, that contain added sugar. Their widespread consumption globally has led to increasing public health scrutiny due to their potential impact on various health outcomes.
Biological Basis
Section titled “Biological Basis”The primary biological concern with SSBs stems from their high content of added sugars, particularly fructose. When consumed, fructose is metabolized in the liver, and this process can lead to increased production of uric acid.[1], [2]Elevated uric acid levels can have downstream effects on human health.
Genetic factors also play a significant role in an individual’s uric acid levels and how they respond to dietary intake, including SSBs. Genome-wide association studies (GWAS) have identified several genes involved in uric acid transport and metabolism that are strongly associated with serum uric acid concentrations. Key among these areSLC2A9 (also known as GLUT9), ABCG2, and SLC17A3. For instance, specific genetic variants such as the missense SNP rs16890979 in SLC2A9, rs2231142 in ABCG2, and rs1165205 in SLC17A3have been linked to higher serum uric acid levels.[3] The SLC2A9gene, in particular, has been consistently associated with serum uric acid levels and exhibits sex-specific effects.[4], [5], [6] Understanding these genetic predispositions can provide insight into individual susceptibility to the health effects of SSB consumption.
Clinical Relevance
Section titled “Clinical Relevance”Consumption of sugar-sweetened beverages is clinically relevant due to its association with several adverse health conditions. Studies have demonstrated a direct link between the intake of added sugar and SSBs and higher serum uric acid concentrations.[7], [8]This elevation in uric acid is a significant risk factor for conditions such as gout, a painful inflammatory arthritis. Research indicates that soft drink and fructose consumption are associated with an increased risk of gout in men.[7]Furthermore, fructose consumption has been linked to a higher risk of developing kidney stones.[9] Beyond these specific conditions, SSBs are also broadly implicated in metabolic health, contributing to concerns related to diabetes and dyslipidemia.
Social Importance
Section titled “Social Importance”The widespread availability and consumption of sugar-sweetened beverages contribute significantly to public health challenges. Given the links to conditions like gout, kidney stones, and other metabolic issues, SSB consumption represents a considerable burden on healthcare systems and public health initiatives. Understanding the biological and genetic underpinnings of these associations is crucial for developing targeted public health strategies, dietary guidelines, and personalized interventions aimed at mitigating the adverse health impacts of SSBs.
Methodological and Statistical Constraints
Section titled “Methodological and Statistical Constraints”Many genome-wide association studies (GWAS), despite often involving large sample sizes, may still lack sufficient statistical power to robustly detect genetic variants with small effect sizes, which could lead to an underestimation of true associations or inflated effect sizes for those variants that are detected.[10]This limitation suggests that a comprehensive understanding of the genetic architecture influencing sugar-sweetened beverage consumption might be incomplete, with many genuine genetic contributions remaining undiscovered. Furthermore, the reliance on a subset of all possible SNPs, even when supplemented by imputation based on reference panels like HapMap build 35 with specificRSQR thresholds, means that some causal variants or genes not in strong linkage disequilibrium with genotyped or imputed markers could be entirely missed.[11] A significant challenge in interpreting GWAS findings is the potential for inconsistencies in replication across different cohorts, which can stem from initial false positive discoveries, true biological differences between study populations, or inadequate statistical power in replication cohorts.[10] Methodological variations across studies, such as differing genotyping quality control procedures or the use of fixed-effects meta-analysis without thorough assessment of heterogeneity, can further complicate the synthesis and generalizability of findings.[11]Such discrepancies highlight the critical need for rigorous and independent validation of genetic associations with sugar-sweetened beverage consumption to ensure the reliability and broader applicability of research outcomes.
Generalizability and Phenotype Measurement Challenges
Section titled “Generalizability and Phenotype Measurement Challenges”A common limitation in current genetic research is the predominant inclusion of cohorts consisting largely of individuals of European descent, often in middle-aged to elderly age ranges.[10]This demographic uniformity restricts the generalizability of any identified genetic influences on sugar-sweetened beverage consumption to younger populations or to individuals from more diverse ethnic and racial backgrounds, where genetic predispositions and environmental factors may interact differently. Additionally, the timing of DNA collection, if performed later in the study, can introduce a survival bias, potentially skewing results by disproportionately including individuals who have lived longer and thus influencing the observed genetic associations.[10]The accurate and consistent characterization of sugar-sweetened beverage consumption itself presents methodological hurdles, as dietary intake data can be prone to recall bias or misreporting. While studies prioritize quality control in phenotype assessment, variations in data collection methods, or the application of specific exclusion criteria—such as removing individuals with pre-existing conditions like diabetes or those using certain medications—can influence the observed genetic associations.[12] Moreover, conducting only sex-pooled analyses may inadvertently obscure sex-specific genetic effects on consumption patterns, leading to an incomplete understanding of how genetic factors operate differently between males and females.[13]
Environmental Confounding and Unexplained Variation
Section titled “Environmental Confounding and Unexplained Variation”Genetic associations with complex dietary behaviors like sugar-sweetened beverage consumption are highly susceptible to confounding by a myriad of environmental and lifestyle factors, including age, body mass index, smoking status, and menopausal or hormone-therapy use, even when statistical adjustments are applied.[12] Despite efforts to control for known confounders, residual confounding from unmeasured or imperfectly measured environmental variables can persist, making it difficult to isolate the precise genetic contributions. The intricate nature of gene-by-environment (GxE) interactions further complicates interpretation, as the effect of a genetic variant on consumption may be significantly modified by an individual’s specific environmental exposures, challenging efforts to fully delineate genetic predispositions from contextual influences.[3] Despite the identification of numerous genetic loci, a substantial portion of the heritability for complex traits, including aspects of dietary intake, frequently remains “missing” or unexplained by common genetic variants.[14]This unexplained variation suggests that rare genetic variants, structural genomic changes, epigenetic modifications, or more complex gene-gene interactions may play significant but currently uncharacterized roles in influencing sugar-sweetened beverage consumption. Bridging the gap between statistical association and biological mechanism requires extensive functional validation of identified variants, which represents a continuous knowledge gap in translating genetic discoveries into a comprehensive understanding of their biological impact.[10]
Variants
Section titled “Variants”The _FTO_(Fat Mass and Obesity-associated) gene plays a significant role in determining an individual’s predisposition to obesity and influencing various metabolic traits. Variants within this gene, such asrs55872725 , are extensively studied for their impact on body weight regulation and energy homeostasis. These genetic variations are understood to affect satiety signaling, overall food intake, and energy expenditure, thereby contributing to the risk of obesity and related metabolic conditions. The interplay between these genetic factors and dietary habits, including the consumption of sugar-sweetened beverages (SSBs), is a critical area of research.[12] Specific _FTO_ variants, including rs55872725 and other commonly studied polymorphisms within the _FTO_ locus like rs8050136 , have been associated with altered food preferences. Individuals carrying certain alleles may exhibit a heightened preference for high-fat and high-sugar foods, which can directly lead to increased intake of SSBs. The _FTO_gene is involved in regulating key hormones such as ghrelin and leptin, which are crucial for controlling hunger and satiety signals in the brain. This genetic predisposition can amplify the impact of readily available sugary drinks on weight gain and the development of metabolic syndrome, influencing caloric intake beyond the direct energy provided by the beverages themselves.[12] Beyond _FTO_, several other genes contribute to the broader genetic landscape of metabolic traits influenced by SSB consumption. Variants in genes like _SLC2A9_ (Solute Carrier Family 2 Member 9), such as rs16890979 and rs6449213 , and _ABCG2_(ATP Binding Cassette Subfamily G Member 2), includingrs2231142 , are strongly associated with serum uric acid levels.[3]High fructose intake, a primary component of SSBs, is a recognized contributor to hyperuricemia, increasing the risk of conditions like gout and kidney stones.[7] Additionally, variants in the _GCKR_(Glucokinase Regulator) gene, such asrs780094 , influence triglyceride levels, while_FADS1_ (Fatty Acid Desaturase 1) variants like rs174548 impact the metabolism of polyunsaturated fatty acids and are linked to cholesterol levels.[15]These diverse genetic influences highlight the complex interplay between genes and diet in shaping an individual’s metabolic health in response to sugar-sweetened beverage consumption.
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs55872725 | FTO | systolic blood pressure, alcohol drinking physical activity measurement appendicular lean mass body mass index body fat percentage |
Fructose Metabolism and Uric Acid Dysregulation
Section titled “Fructose Metabolism and Uric Acid Dysregulation”Consumption of sugar-sweetened beverages, particularly those high in fructose, significantly impacts metabolic pathways, leading to alterations in uric acid homeostasis. Fructose, a component of these beverages, is metabolized primarily in the liver through a pathway that bypasses the regulatory steps of glucose metabolism, leading to rapid phosphorylation and depletion of cellular ATP. This process generates adenosine monophosphate (AMP), which is then catabolized to inosine, hypoxanthine, and ultimately uric acid.[1]Elevated uric acid levels in the blood, known as hyperuricemia, are a direct consequence of increased fructose intake.[1]The transport of uric acid is a critical component of its homeostasis, with theSLC2A9 gene, also known as GLUT9, playing a central role. This gene encodes a facilitative glucose transporter, but it has also been identified as a significant urate transporter, influencing serum uric acid concentration and excretion.[16] Common nonsynonymous variants in GLUT9have been associated with serum uric acid levels, and its splice variants are expressed in the liver and kidney, with upregulation observed in diabetes.[6]Disruptions in urate transport due to genetic variation inGLUT9or increased uric acid production from fructose metabolism can lead to pathophysiological conditions such as gout, characterized by inflammatory arthritis, and an increased risk of kidney stones.[7]
Genetic Influence on Glucose and Insulin Homeostasis
Section titled “Genetic Influence on Glucose and Insulin Homeostasis”Genetic mechanisms play a crucial role in an individual’s susceptibility to the metabolic consequences of sugar-sweetened beverage consumption, particularly concerning glucose and insulin regulation. Several genes have been identified through genome-wide association studies to influence diabetes-related traits and glucose metabolism. For instance, variants nearG6PC2-ABCB1are associated with glucose levels, while variants inMTNR1Bare linked to glucose and are thought to mediate melatonin’s inhibitory effect on insulin secretion, thereby impacting blood sugar control.[17] The PANK1gene, encoding pantothenate kinase, an enzyme vital for coenzyme A synthesis, has also been associated with insulin levels, with mouse studies showing a hypoglycemic phenotype upon its chemical knockout.[17]Beyond direct glucose regulation, genetic variations influence insulin sensitivity and the risk of type 2 diabetes. A common polymorphism inPPAR-gamma(Peroxisome Proliferator-Activated Receptor gamma) is associated with a decreased risk of type 2 diabetes, highlighting its role in adipogenesis and insulin sensitization.[18] Similarly, variants in genes encoding pancreatic β-cell KATP channel subunits, such as KCNJ11 (Kir6.2) and ABCC8 (SUR1), specifically the KCNJ11 E23K variant, are confirmed to be associated with type 2 diabetes.[18] Furthermore, common genetic variation near MC4R(Melanocortin 4 Receptor) has been associated with waist circumference and insulin resistance, suggesting its involvement in energy balance and metabolic health.[19] The HK1gene, encoding hexokinase 1, has also shown a novel association with glycated hemoglobin levels in non-diabetic populations, indicating its role in glucose phosphorylation and overall glycemic control.[12]
Systemic Metabolic Consequences: Lipids and Cardiovascular Risk
Section titled “Systemic Metabolic Consequences: Lipids and Cardiovascular Risk”The biological impact of sugar-sweetened beverage consumption extends to systemic metabolic disruptions, notably affecting lipid profiles and increasing cardiovascular risk. High intake of added sugars and sugar-sweetened drinks has been linked to adverse changes in blood lipids, contributing to dyslipidemia, which includes high low-density lipoprotein (LDL) cholesterol, low high-density lipoprotein (HDL) cholesterol, and elevated triglycerides.[20]These lipid imbalances are key components of the metabolic syndrome, a cluster of conditions that collectively increase the risk of heart disease, stroke, and type 2 diabetes.[21]Specific genetic factors also modulate an individual’s lipid response and subsequent cardiovascular risk. For instance, a null mutation in theAPOC3gene has been shown to confer a favorable plasma lipid profile and apparent cardioprotection, illustrating the significant role of this gene in triglyceride metabolism.[22] Genome-wide association studies have identified numerous loci that contribute to polygenic dyslipidemia and influence lipid concentrations.[20]The interplay between dietary sugar intake and genetic predispositions in lipid metabolism exacerbates the risk of developing conditions like hypertension and coronary artery disease.[23]
Tissue-Specific Responses and Pathophysiological Pathways
Section titled “Tissue-Specific Responses and Pathophysiological Pathways”The biological effects of sugar-sweetened beverage consumption manifest through specific responses at the tissue and organ level, leading to a cascade of pathophysiological processes. The liver is a primary site for fructose metabolism, where excessive intake can lead to increased de novo lipogenesis, contributing to fatty liver disease and dyslipidemia.[21]This metabolic overload can disrupt normal hepatic cellular functions and regulatory networks. The kidneys also play a crucial role, not only in filtering metabolites but also in actively transporting uric acid, a process influenced by genes likeGLUT9.[16]High uric acid levels, often induced by fructose, can contribute to renal damage and the formation of kidney stones.[9]The pancreas, particularly its islet cells, is central to glucose homeostasis through insulin secretion. Chronic high sugar intake can lead to increased demand for insulin, potentially causing pancreatic beta-cell dysfunction and insulin resistance, a hallmark of type 2 diabetes.[18]Over time, these homeostatic disruptions can lead to compensatory responses that ultimately fail, resulting in systemic consequences such as the metabolic syndrome. This syndrome encompasses a range of issues including central obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels, highlighting the interconnectedness of various organ systems in responding to dietary challenges.[21]
Metabolic and Renal Health Implications
Section titled “Metabolic and Renal Health Implications”Consumption of sugar-sweetened beverages (SSBs), characterized by high fructose content, has been consistently linked to adverse metabolic outcomes. Research indicates that elevated intake of added sugars and SSBs is significantly associated with higher serum uric acid concentrations in both men and women.[7]This fructose-induced hyperuricemia is hypothesized to serve as a causal mechanism underlying the development and progression of metabolic syndrome . Furthermore, fructose intake is also associated with an increased risk of kidney stone formation.[9]These findings highlight the prognostic value of routine dietary assessment in identifying individuals at risk for a spectrum of renal and metabolic disorders, underscoring the long-term implications of habitual SSB consumption on patient health and disease progression.
Cardiovascular Disease Risk and Overlapping Syndromes
Section titled “Cardiovascular Disease Risk and Overlapping Syndromes”The metabolic disturbances initiated by high sugar-sweetened beverage intake extend significantly to cardiovascular health. Elevated serum uric acid, a direct consequence of fructose consumption, has been recognized for its crucial significance in both renal and cardiovascular disease.[21]This association suggests a discernible pathway through which SSBs contribute to the development or exacerbation of various cardiovascular conditions, often overlapping with the characteristic features of metabolic syndrome.
Understanding these overlapping phenotypes is critical for comprehensive and integrated patient care. Individuals with high SSB consumption may present with a syndromic constellation of hyperuricemia, metabolic syndrome, and increased cardiovascular risk, necessitating a holistic approach to diagnostic evaluation and therapeutic management. The prognostic value lies in recognizing SSB intake as a modifiable environmental factor that influences a cascade of interconnected health issues, thereby profoundly impacting long-term cardiovascular outcomes.
Risk Stratification and Clinical Interventions
Section titled “Risk Stratification and Clinical Interventions”In clinical practice, assessing a patient’s sugar-sweetened beverage consumption serves as a valuable, non-invasive tool for risk stratification, enabling the identification of individuals at high risk for developing hyperuricemia, gout, kidney stones, and metabolic syndrome. This detailed dietary information can inform personalized medicine approaches, particularly in populations with pre-existing metabolic vulnerabilities or genetic predispositions. Early identification through such assessments allows for the implementation of targeted primary prevention strategies focused on comprehensive dietary modification.
Clinical applications of this knowledge include counseling patients on reducing or eliminating SSB intake as a primary intervention, which can be effectively monitored through detailed dietary recall or food frequency questionnaires. For patients already presenting with elevated uric acid levels or early signs of metabolic dysfunction, a thorough assessment of SSB consumption aids in treatment selection and reinforces lifestyle changes as a cornerstone of management. Integrating a detailed dietary history, with particular attention to SSB consumption patterns, is essential for proactive patient care and mitigating the progression of these interconnected diseases.
Frequently Asked Questions About Sugar Sweetened Beverage Consumption Measurement
Section titled “Frequently Asked Questions About Sugar Sweetened Beverage Consumption Measurement”These questions address the most important and specific aspects of sugar sweetened beverage consumption measurement based on current genetic research.
1. Why do I avoid soda but still struggle with my weight?
Section titled “1. Why do I avoid soda but still struggle with my weight?”That’s a great question, as genetics can influence your body in complex ways. A specific variant (rs55872725 ) in the FTO gene, which is linked to a higher BMI, has been counterintuitively associated with lowersugar-sweetened beverage consumption. This suggests that your genes can affect body weight through mechanisms beyond just your intake of sugary drinks, perhaps by influencing how your body processes different types of food.
2. Do my genes make me crave sugary drinks more?
Section titled “2. Do my genes make me crave sugary drinks more?”Yes, your genetic makeup can influence your preference for and intake of sugary drinks. While many factors play a role, specific genetic variants, like one in the FTO gene (rs55872725 ), have been linked to how much sugar-sweetened beverages you consume. This means some people might have a genetic predisposition that makes them more or less inclined to choose these drinks.
3. Will my kids inherit my sweet tooth for sodas?
Section titled “3. Will my kids inherit my sweet tooth for sodas?”It’s possible for your children to inherit genetic predispositions related to beverage choices. Research shows that certain genetic variants, such as one in the FTO gene (rs55872725 ), can influence sugar-sweetened beverage consumption. While genetics play a role, environmental factors like family habits and cultural influences also strongly shape what your children choose to drink.
4. Does my family’s background affect my risk for drinking too much soda?
Section titled “4. Does my family’s background affect my risk for drinking too much soda?”Yes, your ancestry can be a factor, but current research has limitations. Most studies on genetic links to sugar-sweetened beverage consumption, including the variant in the FTO gene, have primarily focused on populations of European ancestry. Therefore, it’s important to be cautious when applying these findings to other diverse populations, as different ancestral groups may have unique genetic risk factors.
5. Can I really beat my genes if I try to cut back on soda?
Section titled “5. Can I really beat my genes if I try to cut back on soda?”Absolutely, you can significantly influence your consumption habits despite genetic predispositions. While genes like FTO can play a role in how much sugar-sweetened beverages you consume, strong environmental factors and conscious lifestyle choices have a powerful impact. Making consistent efforts to reduce intake and choosing healthier alternatives can effectively overcome genetic tendencies.
6. Why is it so hard for me to stop drinking sugary sodas?
Section titled “6. Why is it so hard for me to stop drinking sugary sodas?”It can be challenging because your preference for sugary drinks is shaped by a complex interplay of genetics and environment. Certain genetic variants, such as one in the FTO gene, can influence your susceptibility to consuming these beverages. Additionally, strong environmental factors like social norms, advertising, and the availability of sugary drinks can make it difficult to change established habits.
7. Could a DNA test tell me if I should avoid sugary drinks?
Section titled “7. Could a DNA test tell me if I should avoid sugary drinks?”A DNA test might identify specific genetic variants, like rs55872725 in the FTO gene, that are associated with sugar-sweetened beverage consumption. This information could offer some insight into your genetic predisposition. However, genetic effects are often small, and lifestyle and environmental factors play a much larger role, so a test alone won’t give a complete picture or definitive advice.
8. Do some people just taste sweetness differently than me?
Section titled “8. Do some people just taste sweetness differently than me?”Yes, individual differences in taste perception can influence beverage choices. Research suggests that variations in how people perceive taste intensity, even within the same beverage types, might play a role in their consumption patterns. This variability in how strongly you experience sweetness could subtly influence your preference for or avoidance of sugar-sweetened beverages.
9. Does my busy life make my genes less important for my soda intake?
Section titled “9. Does my busy life make my genes less important for my soda intake?”Yes, strong environmental factors from your daily life, such as your social circle, work environment, and cultural influences, can significantly impact your beverage choices. These powerful external forces can sometimes mask or overshadow the underlying genetic predispositions you might have, making environmental factors appear more dominant in determining your sugar-sweetened beverage consumption.
10. My friend drinks lots of soda but is thin; why am I not?
Section titled “10. My friend drinks lots of soda but is thin; why am I not?”This can happen due to the complex interplay of genetics and other factors. While sugar-sweetened beverages are linked to health issues, some individuals carry genetic variants, like rs55872725 in the FTO gene, that are associated with higher BMI but lowerSSB consumption. This suggests that genetic influences on body weight can operate independently of sugary drink intake, through other dietary factors or metabolic processes.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Emmerson, B. T. “Effect of oral fructose on urate production.”Ann Rheum Dis, vol. 33, no. 3, 1974, pp. 276–80.
[2] Perheentupa, J et al. “Fructose-induced hyperuricaemia.”Lancet, vol. 2, no. 7515, 1967, pp. 528-31.
[3] Dehghan, A., et al. “Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.”Lancet, vol. 372, no. 9654, 2008, pp. 1858-64.
[4] Doring, A et al. “SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.”Nat Genet, vol. 40, no. 4, 2008, pp. 430-6.
[5] Li, S et al. “The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.”PLoS Genet, vol. 3, no. 11, 2007, e194.
[6] McArdle, P. F. “Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish.”Arthritis Rheum, vol. 59, no. 9, 2008, pp. 1314-20.
[7] Choi, H. K., & Curhan, G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008; 336(7639):309–12.
[8] Gao, X et al. “Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women.”Hypertension, vol. 50, no. 2, 2007, pp. 306-12.
[9] Taylor, E. N., & Curhan, G. C. Fructose consumption and the risk of kidney stones. Kidney Int. 2008; 73(2):207–12.
[10] Benjamin, E. J., et al. “Genome-wide association with select biomarker traits in the Framingham Heart Study.” BMC Med Genet, vol. 8, 2007, p. 62. PMID: 17903293.
[11] Yuan, X., et al. “Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.” Am J Hum Genet, vol. 83, no. 5, 2008, pp. 583-594. PMID: 18940312.
[12] Pare, G et al. “Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women’s Genome Health Study.”PLoS Genet, vol. 4, no. 12, 2008, e1000312.
[13] Yang, Q., et al. “Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.”BMC Med Genet, vol. 8, 2007, p. 57. PMID: 17903294.
[14] Benyamin, B., et al. “Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.”Am J Hum Genet, vol. 84, no. 1, 2009, pp. 60-65. PMID: 19084217.
[15] Wallace, C., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008; 82(1):139–49.
[16] Vitart, V et al. “SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.”Nat Genet, vol. 40, no. 4, 2008, pp. 437-42.
[17] Sabatti, C et al. “Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.”Nat Genet, vol. 41, no. 1, 2009, pp. 35-46.
[18] Meigs, JB et al. “Genome-wide association with diabetes-related traits in the Framingham Heart Study.” BMC Med Genet, vol. 8, Suppl 1, 2007, S15.
[19] Chambers, JC et al. “Common genetic variation near MC4R is associated with waist circumference and insulin resistance.”Nat Genet, vol. 40, no. 5, 2008, pp. 719-21.
[20] Kathiresan, S et al. “Common variants at 30 loci contribute to polygenic dyslipidemia.” Nat Genet, vol. 41, no. 1, 2009, pp. 56-65.
[21] Nakagawa, T et al. “Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.”Nat Clin Pract Nephrol, vol. 1, no. 2, 2005, pp. 80-6.
[22] Pollin, TI et al. “A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.” Science, vol. 322, no. 5906, 2008, pp. 1702-5.
[23] “Genome-wide mapping of human loci for essential hypertension.”Lancet, vol. 361, no. 9375, 2003, pp. 2118-23.